Physician profile
Roger D Johnson
NPI 1093949687
$2,131.03
in general payments reported to CMS, 2019-2025
20 companies · $214 in 2025
The $214 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $608 · 2020: $216 · 2021: $93.50 · 2022: $224 · 2023: $228 · 2024: $548 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $990.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $989.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $637.05 | 2019-2025 | Clareon, Argos, Rocklatan |
| Bausch & Lomb Americas INC. | $276.30 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Glaukos Corporation | $201.49 | 2019-2024 | Idose, Istent Trabecular Micro-Bypass System Model Is3 |
| Biotissue Holdings INC. | $173.59 | 2019-2020 | |
| Medtronic, INC. | $137.82 | 2022 | |
| Abbvie INC. | $127.18 | 2023-2024 | |
| Rxsight INC | $75.56 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Novartis Pharmaceuticals Corporation | $75.18 | 2020-2023 | |
| Johnson & Johnson Surgical Vision, INC. | $71.30 | 2019-2021 | |
| Shire North American Group INC | $68.59 | 2019 | |
| Mallinckrodt Hospital Products INC. | $59.07 | 2020-2023 | Acthar |
| Harrow Eye, LLC | $32.38 | 2025 | Vevye |
| Dompe US, INC. | $30.75 | 2024 | Oxervate |
| New World Medical,INC. | $28.85 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $25.35 | 2025 | Xdemvy |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $24.70 | 2023 | |
| Eyepoint US, INC. | $24.04 | 2022 | |
| Aerie Pharmaceuticals, INC. | $21.52 | 2019 | |
| Sun Pharmaceutical Industries INC. | $20.58 | 2019 | |
| Allergan, INC. | $19.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.